MatsukiyoCocokara & Co. (3088)

Name: MatsukiyoCocokara & Co. (3088) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Healthcare · Wall Street (EE. UU.) · Última actualización: 2026-09-30

MatsukiyoCocokara & Co. operates and manages chain stores, drug stores, and insurance dispensing pharmacies in Japan. The company is involved in franchise business development and product supply to franchisees, as well as management support services. It offers its products under the nake and RECiPEO brand names. MatsukiyoCocokara & Co. was founded in 1932 and is headquartered in Tokyo, Japan.

Cifras clave

Capitalización bursátil: JPY 958 billion
Ingresos (ejercicio cerrado en 2026-03-31): JPY 1.12T
Beneficio neto: JPY 55.8B
Margen bruto: 35.2%
Margen neto: 5.0%

Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →

Cuenta de resultados anual

Cuenta de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Ingresos totales	JPY 1.12T	JPY 1.06T	JPY 1.02T	JPY 951.2B	—
Beneficio bruto	JPY 393.8B	JPY 372.2B	JPY 354.1B	JPY 329.3B	—
Ingresos operativos (EBIT)	JPY 84.9B	JPY 82.1B	JPY 75.7B	JPY 62.3B	—
Ingresos netos	JPY 55.8B	JPY 54.7B	JPY 52.3B	JPY 40.5B	—

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de 3088. /companies/us/3088

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.